Blanck G - Search Results

1

Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX.

Niesen MI, Osborne AR, Yang H, Rastogi S, Chellappan S, Cheng JQ, Boss JM, Blanck G. Niesen MI, et al. Among authors: blanck g. J Biol Chem. 2005 Nov 25;280(47):38914-22. doi: 10.1074/jbc.M504633200. Epub 2005 Sep 15. J Biol Chem. 2005. PMID: 16166088 Free article.

2

Retinoblastoma protein regulation of surface CD74 (invariant chain) expression in breast carcinoma cells.

Lu Y, Ussery GD, Jacim M, Tschickardt M, Boss JM, Blanck G. Lu Y, et al. Among authors: blanck g. Mol Immunol. 1994 Dec;31(17):1365-8. doi: 10.1016/0161-5890(94)90055-8. Mol Immunol. 1994. PMID: 7997248

3

Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.

Lu Y, Boss JM, Hu SX, Xu HJ, Blanck G. Lu Y, et al. Among authors: blanck g. J Immunol. 1996 Apr 1;156(7):2495-502. J Immunol. 1996. PMID: 8786310

4

Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.

Osborne A, Tschickardt M, Blanck G. Osborne A, et al. Among authors: blanck g. Nucleic Acids Res. 1997 Dec 15;25(24):5095-102. doi: 10.1093/nar/25.24.5095. Nucleic Acids Res. 1997. PMID: 9396821 Free PMC article.

5

Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.

Eason DD, Shepherd AT, Blanck G. Eason DD, et al. Among authors: blanck g. Biochim Biophys Acta. 1999 Jul 7;1446(1-2):140-4. doi: 10.1016/s0167-4781(99)00078-0. Biochim Biophys Acta. 1999. PMID: 10395927

6

Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression.

Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY, Wu GD, Blanck G. Zhang H, et al. Among authors: blanck g. Cell Growth Differ. 1999 Jul;10(7):457-65. Cell Growth Differ. 1999. PMID: 10437913

7

Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.

Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL, Blanck G. Xi H, et al. Among authors: blanck g. Oncogene. 1999 Oct 21;18(43):5889-903. doi: 10.1038/sj.onc.1202969. Oncogene. 1999. PMID: 10557076

8

Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.

Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Goodwin BL, et al. Among authors: blanck g. Cell Growth Differ. 2001 Jun;12(6):327-35. Cell Growth Differ. 2001. PMID: 11432807

9

Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.

Xi H, Goodwin B, Shepherd AT, Blanck G. Xi H, et al. Among authors: blanck g. Oncogene. 2001 Jul 12;20(31):4219-27. doi: 10.1038/sj.onc.1204556. Oncogene. 2001. PMID: 11464288

10

Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.

Osborne A, Zhang H, Yang WM, Seto E, Blanck G. Osborne A, et al. Among authors: blanck g. Mol Cell Biol. 2001 Oct;21(19):6495-506. doi: 10.1128/MCB.21.19.6495-6506.2001. Mol Cell Biol. 2001. PMID: 11533238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters